Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stent implantation in a real-world population: a comparison with paclitaxel-eluting stents: the PORI registry.
Karjalainen
Pasi P
PP
Department of Cardiology, Satakunta Central Hospital, Sairaalantie 3, FIN-28100, Pori, Finland. pasi.karjalainen@satshp.fi
Ylitalo
Antti
A
Airaksinen
Juhani Ke
JK
Nammas
Wail
W
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000706:statistics & numerical data*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D016001:Confidence Intervals; D003324:Coronary Artery Disease / Q000401:mortality / Q000517:prevention & control / Q000628:therapy*; D023903:Coronary Restenosis / Q000401:mortality / Q000517:prevention & control / Q000628:therapy; D054855:Drug-Eluting Stents; D005260:Female; D005387:Finland; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D017239:Paclitaxel / Q000627:therapeutic use*; D057216:Propensity Score; D011446:Prospective Studies; D012042:Registries; D013997:Time Factors; D014025:Titanium / Q000737:chemistry*; D016896:Treatment Outcome
D000972:Antineoplastic Agents, Phytogenic; C434243:titanium-nitride-oxide; D014025:Titanium; D017239:Paclitaxel